Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study

Alimentary Pharmacology and Therapeutics

Volumn 23, Issue 1, 2006, Pages 145-154

  Hoepffner, N ^a   Shastri, Y M ^a   Hanisch, E ^b   Rosch W ^c   Mossner J ^d   Caspary, W F ^a   Stein, J ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Asklepios Klinik   (Germany)

^c Nord West Hospital   (Germany)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ARTICLE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OCCULT BLOOD; OCCULT BLOOD TEST; PATIENT REFERRAL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; GUAIAC; HUMANS; INDICATORS AND REAGENTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAGENT STRIPS; SENSITIVITY AND SPECIFICITY;

EID: 33644924933     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02702.x     Document Type: Article

References (45)

1. Parkin DM Bray F Ferlay J Pisani P Global cancer statistics, 2002 CA Cancer J Clin 2005 55 74 108
2. Boyle P Ferlay J Cancer incidence and mortality in Europe, 2004 Ann Oncol 2005 16 481 8
3. Jemal A Murray T Ward E et al. Cancer statistics, 2005 CA Cancer J Clin 2005 55 10 30
4. Walsh JM Terdiman JP Colorectal cancer screening: scientific review JAMA 2003 289 1288 96
5. Bresalier RS Malignant neoplasms of the large intestine In Feldman M Friedman LS Sleisinger MH eds Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management Philadelphia, USA W.B. Saunders 2002 2215 56
6. Allison JE Review article: Faecal occult blood testing for colorectal cancer Aliment Pharmacol Ther 1998 12 1 10
7. Mandel JS Bond JH Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 1993 328 1365 71
8. Hardcastle JD Chamberlain JO Robinson MHE et al. Randomised controlled trial of faecal occult-blood screening for colorectal cancer Lancet 1996 348 1472 7
9. Kronborg O Fenger C Olsen J Jorgensen OD Sondergaard O Randomised study of screening for colorectal cancer with faecal-occult-blood test Lancet 1996 348 1467 71
10. Faivre J Dancourt V Lejeune C et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study Gastroenterology 2004 126 1674 80
11. Allison JE Feldman R Tekawa IS Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting Ann Intern Med 1990 112 328 33
12. Ahlquist DA Wieand HS Moertel CG et al. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests JAMA 1993 269 1262 7
13. Allison JE Tekawa IS Ransom LJ Adrain AL A comparison of fecal occult-blood tests for colorectal-cancer screening N Engl J Med 1996 334 155 9
14. Lieberman DA Weiss DG One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon N Engl J Med 2001 345 555 60
15. Ouyang DL Chen JJ Getzenberg RH Schoen RE Noninvasive testing for colorectal cancer: a review Am J Gastroenterol 2005 100 1393 403
16. Macrae FA St John DJ Caligiore P Optimal dietary conditions for Hemoccult testing Gastroenterology 1982 82 899 903
17. Sieg A Thoms C Luthgens K John MR Schmidt-Gayk H Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces Int J Colorectal Dis 1999 14 267 71
18. Petrelli N Michalek AM Freedman A Baroni M Mink I Rodriguez-Bigas M Immunochemical versus Guaiac occult blood stool tests: results of a community-based screening program Surg Oncol 1994 3 27 36
19. Cole SR Young GP Esterman A Cadd B Morcom J A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer J Med Screen 2003 10 117 22
20. Saito H Soma Y Koeda J et al. Reduction in risk of mortality from colorectal cancer by fecal occult blood screening with immunochemical hemagglutination test. A case-control study Int J Cancer 1995 61 465 9
21. Castiglione G Zappa M Grazzini G et al. Immunochemical vs Guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer Br J Cancer 1996 74 141 4
22. Nelson DB McQuaid KR Bond JH Lieberman DA Weiss DG Johnston TK Procedural success and complications of large-scale screening colonoscopy Gastrointest Endosc 2002 55 307 14
23. Morikawa T Kato J Yamaji Y Wada R Mitsushima T Shiratori Y A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population Gastroenterology 2005 129 422 8
24. Trojan J Povse N Schroder O Stein J A new immunological test strip device for the rapid, qualitative detection of faecal occult blood Z Gastroenterol 2002 40 921 4
25. Hulley SB Cummings SR Designing Clinical Research Baltimore, USA Williams & Wilkins 1988
26. Ahlquist DA McGill DB Fleming JL et al. Patterns of occult bleeding in asymptomatic colorectal cancer Cancer 1989 63 1826 30
27. Ahlquist DA McGill DB Schwartz S Taylor WF Owen RA Fecal blood levels in health and disease. A study using HemoQuant N Engl J Med 1985 312 1422 8
28. Saito H Screening for colorectal cancer by immunochemical fecal occult blood testing Jpn J Cancer Res 1996 87 1011 24
29. Ahlquist DA Shuber AP Stool screening for colorectal cancer: evolution from occult blood to molecular markers Clin Chim Acta 2002 315 157 68
30. Lein M Jung K Schnorr D Henke W Loening SA Strip test for the quick detection of increased concentrations of prostate-specific antigen in blood Eur J Clin Chem Clin Biochem 1996 34 511 4
31. Muller-Bardorff M Rauscher T Kampmann M et al. Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing Clin Chem 1999 45 1002 8
32. Rozen P Knaani J Samuel Z Eliminating the need for dietary restrictions when using a sensitive Guaiac fecal occult blood test Dig Dis Sci 1999 44 756 60
33. Rozen P Knaani J Samuel Z Comparative screening with a sensitive Guaiac and specific immunochemical occult blood test in an endoscopic study Cancer 2000 89 46 52
34. Greenberg PD Bertario L Gnauck R et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy Am J Gastroenterol 2000 95 1331 8
35. Wong BC Wong WM Cheung KL et al. A sensitive Guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population Aliment Pharmacol Ther 2003 18 941 6
36. Howarth GF Robinson MH Jenkins D Hardcastle JD Logan RF High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial Am J Gastroenterol 2002 97 690 4
37. Sakata T Niwa Y Goto H et al. Asymptomatic inflammatory bowel disease with special reference to ulcerative colitis in apparently healthy persons Am J Gastroenterol 2001 96 735 9
38. Ahlquist DA Skoletsky JE Boynton KA et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 2000 119 1219 27
39. Woolf SH A smarter strategy? Reflections on fecal DNA screening for colorectal cancer N Engl J Med 2004 351 2755 8
40. Imperiale TF Ransohoff DF Itzkowitz SH Turnbull BA Ross ME Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population N Engl J Med 2004 351 2704 14
41. Allison JE Colon Cancer Screening Guidelines 2005: the fecal occult blood test option has become a better fit Gastroenterology 2005 129 745 8
42. Hixson LJ Fennerty MB Sampliner RE McGee D Garewal H Prospective study of the frequency and size distribution of polyps missed by colonoscopy J Natl Cancer Inst 1990 82 1769 72
43. Rex DK Cutler CS Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies Gastroenterology 1997 112 24 8
44. St John DJ Young GP Alexeyeff MA et al. Evaluation of new occult blood tests for detection of colorectal neoplasia Gastroenterology 1993 104 1661 8
45. Gopalswamy N Stelling HP Markert RJ Maimon HN Wahlen SD Haddy RI A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated Arch Fam Med 1994 3 1043 8